Co-Diagnostics Inc (CODX) Stock Price, Quote & News

Company Profile

Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers Co-Dx PCR platform, a polymerase chain reaction testing to patients in point-of-care and at-home setting. The company also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, malaria, dengue, hum...

Industry: Medical Devices

Sector: Healthcare

Phone: 801 438 1036

Website: co-dx.com

Address:

2401 S. Foothill Drive, Suite D, Salt Lake City, United States

csabuus Jun. 25 at 6:43 AM

$CODX GO to 10

0 · Reply

Minutiae Jun. 25 at 4:16 AM

$CODX Jun 24 Full day chart. https://www.nasdaq.com/market-activity/stocks/codx

0 · Reply

Minutiae Jun. 25 at 4:15 AM

$CODX Jun 24 CODX volume 992,390 closing at $3.57. 73,270 after-hour shares trading at $3.47 to $3.5937. FINRA Short Sale Volume 351,710 shorted shares out of 622,900. CODX short volume 56%. https://www.nasdaq.com/market-activity/stocks/codx/advanced-charting

0 · Reply

SmallPhish Jun. 25 at 3:45 AM

$CODX Dwight should be ready to raise money through stock sales tomorrow now that Ebola traders are triggered.

1 · Reply

CoffeeRocks Jun. 25 at 2:39 AM

$CODX https://share.google/2krq8E4kSSOwJ81o6

0 · Reply

CoffeeRocks Jun. 25 at 2:33 AM

$BTAI $RLAY $ABSI $CODX Bio stocks running 🏃‍♂️

0 · Reply

CoffeeRocks Jun. 25 at 1:44 AM

$CODX $AEMD $BTAI $SLS https://share.google/iINko0bnsVQxj6xLn

0 · Reply

Minutiae Jun. 25 at 12:02 AM

$CODX Don't get excited. That $1.4 billion request for Ebola is only PART of Trunp's request for $$$!!! White House seeks $87.6B from Congress for Iran war costs, U.S. farmers and Ebola response PBS News | Politics | Jun 24, 2026 5:52 PM EDT https://www.pbs.org/newshour/politics/white-house-seeks-87-6b-from-congress-for-iran-war-costs-u-s-farmers-and-ebola-response

0 · Reply

Chessdoc Jun. 24 at 11:55 PM

$CODX Let’s get a move on! https://www.unicefusa.org/stories/3-million-children-risk-ebola-cases-top-1000-drc

0 · Reply

Chessdoc Jun. 24 at 8:41 PM

$CODX Exquisitely, beautiful chart!

0 · Reply

Co-Diagnostics signs distribution agreement for CO-Dx PCR Pro in Mexico

Jun 11, 2026, 9:00 AM EDT - 13 days ago

Co-Diagnostics Advances Latin American Commercialization Strategy for Co-Dx™ PCR Pro® with Mexico Distributor Agreement

2026-06-02T14:52:18.000Z - 22 days ago

Co-Diagnostics announces continued progress in Ebola PCR development program

2026-06-02T14:07:28.000Z - 22 days ago

Co-Diagnostics trading halted, volatility trading pause

2026-06-02T13:54:50.000Z - 22 days ago

Co-Diagnostics trading resumes

Jun 2, 2026, 9:00 AM EDT - 22 days ago

Co-Diagnostics and CoSara Advance Ebola PCR Test Development and Co-Dx™ PCR Point-of-Care Platform Capabilities

2026-05-28T21:18:09.000Z - 27 days ago

Co-Diagnostics files to sell 4.94M shares of common stock for holders

May 28, 2026, 8:00 AM EDT - 27 days ago

Co-Diagnostics Registration statement: Registration filing

2026-05-27T15:15:44.000Z - 4 weeks ago

Co-Diagnostics trading halted, volatility trading pause

2026-05-27T15:08:07.000Z - 4 weeks ago

Co-Diagnostics trading resumes

2026-05-26T14:04:46.000Z - 4 weeks ago

Co-Diagnostics and CoSara Diagnostics advance with ebola PCR development

May 26, 2026, 9:00 AM EDT - 4 weeks ago

Co-Diagnostics Advances Ebola PCR Assay Development Strategy with Joint Venture CoSara

May 19, 2026, 10:54 PM EDT - 5 weeks ago

Co-Diagnostics Announces $3.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules

2026-05-19T13:16:13.000Z - 5 weeks ago

Co-Diagnostics develops ebola assay strategy after recent global outbreak alert

May 19, 2026, 9:00 AM EDT - 5 weeks ago

Co-Diagnostics Develops Ebola Assay Strategy Following Recent Global Outbreak Alert

2026-05-14T21:49:36.000Z - 5 weeks ago

Co-Diagnostics reports Q1 EPS ($4.06) vs. ($7.05) last year

May 14, 2026, 4:30 PM EDT - 5 weeks ago

Co-Diagnostics Earnings Call Transcript: Q1 2026

May 14, 2026, 4:30 PM EDT - 5 weeks ago

Co-Diagnostics Earnings release: Q1 2026

May 14, 2026, 4:30 PM EDT - 5 weeks ago

Co-Diagnostics Quarterly report: Q1 2026

May 14, 2026, 4:01 PM EDT - 5 weeks ago

Co-Diagnostics Reports First Quarter 2026 Financial Results

May 14, 2026, 4:00 PM EDT - 5 weeks ago

Co-Diagnostics Slides: Investor presentation

2026-05-12T20:55:31.000Z - 6 weeks ago

Co-Diagnostics files $150M mixed securities shelf

May 12, 2026, 8:00 AM EDT - 6 weeks ago

Co-Diagnostics Registration statement: Registration filing

2026-05-08T15:28:11.000Z - 6 weeks ago

Co-Diagnostics’ joint venture with CoMira finalizes facility lease agreement

May 8, 2026, 9:00 AM EDT - 6 weeks ago

Co-Diagnostics Joint Venture CoMira Finalizes Lease Agreement for Manufacturing Facility in Saudi Arabia's Sudair Industrial City

Apr 30, 2026, 9:00 AM EDT - 7 weeks ago

Co-Diagnostics Announces First Quarter 2026 Earnings Release Date and Webcast

Apr 16, 2026, 9:00 AM EDT - 2 months ago

Co-Diagnostics Invited to Present at Stop TB Partnership Summit in Washington, D.C.

Apr 14, 2026, 9:00 AM EDT - 2 months ago

Co-Diagnostics to Showcase Co-Dx PCR Platform and CE-IVD Solutions at ESCMID 2026 in Munich, Germany

Apr 9, 2026, 9:00 AM EDT - 2 months ago

Co-Diagnostics Executives to Participate in European Trade Mission with Utah Governor and WTC Utah

Mar 31, 2026, 4:30 PM EDT - 3 months ago

Co-Diagnostics Earnings Call Transcript: Q4 2025

Mar 31, 2026, 4:30 PM EDT - 3 months ago

Co-Diagnostics Annual report: Q4 2025

Mar 31, 2026, 4:30 PM EDT - 3 months ago

Co-Diagnostics Earnings release: Q4 2025

Mar 31, 2026, 4:01 PM EDT - 3 months ago

Co-Diagnostics Reports Full Year 2025 Financial Results

Mar 25, 2026, 8:00 AM EDT - 3 months ago

Co-Diagnostics Ships Diagnostic Materials to India for Initiation of Tuberculosis Clinical Studies Following Recently Issued Guidance from the World Health Organization

2026-03-20T12:11:57.000Z - 3 months ago

Co-Diagnostics to expand commercial, distribution territory across South Asia

Mar 20, 2026, 8:00 AM EDT - 3 months ago

Co-Diagnostics Signs Agreement to Significantly Expand Commercial and Distribution Territory Across South Asia

Mar 17, 2026, 9:00 AM EDT - 3 months ago

Co-Diagnostics Announces Fourth Quarter and Full Year 2025 Earnings Release Date and Webcast

Mar 16, 2026, 9:00 AM EDT - 3 months ago

Co-Diagnostics to Present at Medical Korea 2026

Mar 12, 2026, 9:00 AM EDT - 3 months ago

Co-Diagnostics Receives Japanese Patent Covering Co-Dx PCR Platform Technologies

Mar 10, 2026, 9:00 AM EDT - 3 months ago

Co-Diagnostics Regains Compliance with Nasdaq Listing Requirements

Feb 9, 2026, 9:00 AM EST - 4 months ago

Co-Diagnostics to Showcase PCR Platform at World Health Expo Labs Dubai

Feb 5, 2026, 9:00 AM EST - 4 months ago

Co-Diagnostics Joint Venture CoSara Receives CDSCO License to Manufacture and Sell CoSara PCR Pro™ Instrument

Feb 4, 2026, 9:00 AM EST - 5 months ago

Co-Diagnostics JV, CoSara, Receives ISO 13485 Certification in Preparation for Manufacturing Upcoming PCR Platform

2026-01-23T14:10:52.000Z - 5 months ago

Co-Diagnostics cut to Hold at Maxim on Nasdaq delisting

2026-01-23T13:00:47.000Z - 5 months ago

Co-Diagnostics downgraded to Hold from Buy at Maxim

Jan 12, 2026, 9:00 AM EST - 5 months ago

Co-Diagnostics JV CoSara Participates in Regional Conferences to Grow and Strengthen Distributor Relationships

Dec 30, 2025, 9:00 AM EST - 6 months ago

Co-Diagnostics Announces Reverse Stock Split

Dec 29, 2025, 9:00 AM EST - 6 months ago

Co-Diagnostics Receives Grant of Australian Patent Covering Co-Dx PCR Platform Technologies

Dec 18, 2025, 9:00 AM EST - 6 months ago

Co-Diagnostics Joint Venture, CoSara, Invited to Participate in 2nd Advanced TB Diagnostics Course in Chennai, India

Dec 17, 2025, 9:00 AM EST - 6 months ago

Co-Diagnostics Performs Analysis of Influenza Co-Primers® to Confirm Reactivity Against Flu A H3N2 Mutation

Dec 9, 2025, 9:00 AM EST - 7 months ago

Co-Diagnostics to Present on Co-Dx™ PCR Platform and AI Integration at Point-of-Care Testing 2025

Dec 8, 2025, 12:36 PM EST - 7 months ago

Co-Diagnostics JV, CoSara, to Participate at VIROCON 2025 in Pune, India

Nov 20, 2025, 9:00 AM EST - 7 months ago

Co-Diagnostics Delivers Address about Tuberculosis Test Adoption and Implementation at The Union World Conference on Lung Health

Nov 18, 2025, 9:00 AM EST - 7 months ago

Co-Diagnostics Initiates Clinical Evaluations for Upper Respiratory Multiplex Point-of-Care Test on Co-Dx™ PCR Platform to Support Submission to the U.S. FDA

Nov 13, 2025, 4:30 PM EST - 7 months ago

Co-Diagnostics Earnings Call Transcript: Q3 2025

Nov 13, 2025, 4:30 PM EST - 7 months ago

Co-Diagnostics Quarterly report: Q3 2025

Nov 13, 2025, 4:30 PM EST - 7 months ago

Co-Diagnostics Earnings release: Q3 2025

Nov 13, 2025, 4:01 PM EST - 7 months ago

Co-Diagnostics Reports Third Quarter 2025 Financial Results

Nov 10, 2025, 7:00 AM EST - 8 months ago

Co-Diagnostics Proxy statement: Proxy Filing

Nov 5, 2025, 11:00 AM EST - 8 months ago

Co-Diagnostics Transcript: Fireside Chat

Nov 5, 2025, 9:00 AM EST - 8 months ago

Co-Diagnostics Engages Maxim Group to Pursue SPAC Transaction for its Indian Joint Venture, CoSara Diagnostics Pvt. Ltd

Nov 3, 2025, 9:00 AM EST - 8 months ago

Co-Diagnostics to Integrate and Implement Proprietary Artificial Intelligence Technology into Co-Dx™ Primer Ai™ Platform

Oct 31, 2025, 9:00 AM EDT - 8 months ago

Co-Diagnostics, Inc. Announces Third Quarter 2025 Earnings Release Date and Webcast

Oct 31, 2025, 8:00 AM EDT - 8 months ago

Co-Diagnostics Proxy statement: Proxy Filing

Oct 30, 2025, 1:57 PM EDT - 8 months ago

Co-Diagnostics to Host Fireside Chat on November 5th with CEO, Dwight Egan, to Discuss Recently Announced Definitive Agreement in Saudi Arabia

Oct 29, 2025, 12:51 PM EDT - 8 months ago

Co-Diagnostics, Inc. Announces Closing of $7.0 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules

Oct 28, 2025, 9:33 AM EDT - 8 months ago

Co-Diagnostics, Inc. Announces Pricing of $7.0 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules

Oct 22, 2025, 8:30 AM EDT - 8 months ago

Co-Diagnostics Executive Leadership Team to Attend Global Health Exhibition 2025 in Riyadh, Saudi Arabia

Oct 16, 2025, 9:30 AM EDT - 8 months ago

Co-Diagnostics Announces Development of Proprietary Sample Prep Instrument for PoC Testing

Oct 13, 2025, 9:30 AM EDT - 9 months ago

Co-Diagnostics, Inc. to Attend 2025 Maxim Growth Summit

Sep 30, 2025, 4:15 PM EDT - 9 months ago

Co-Diagnostics Transcript: Lytham Partners Fall 2025 Investor Conference

Sep 30, 2025, 9:30 AM EDT - 9 months ago

Co-Diagnostics, Inc. to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30

Sep 18, 2025, 5:05 PM EDT - 9 months ago

Co-Diagnostics, Inc. Announces Closing of $3.8 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules

Sep 17, 2025, 9:47 AM EDT - 10 months ago

Co-Diagnostics, Inc. Announces Pricing of $3.8 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules

Sep 11, 2025, 9:30 AM EDT - 10 months ago

Co-Diagnostics, Inc. Performs Analysis of Chikungunya Co-Primers® to Confirm Reactivity Against Known Virus Strains

Sep 9, 2025, 9:30 AM EDT - 10 months ago

Co-Diagnostics, Inc. Honored at Utah Business 2025 Innovation Awards Summit

Aug 18, 2025, 9:30 AM EDT - 11 months ago

Co-Diagnostics, Inc. to Host Booth at 17th Next Generation Dx Summit in Washington, D.C.

Aug 14, 2025, 4:30 PM EDT - 11 months ago

Co-Diagnostics Earnings Call Transcript: Q2 2025

Aug 14, 2025, 4:30 PM EDT - 11 months ago

Co-Diagnostics Quarterly report: Q2 2025

Aug 14, 2025, 4:30 PM EDT - 11 months ago

Co-Diagnostics Earnings release: Q2 2025

Aug 14, 2025, 4:01 PM EDT - 11 months ago

Co-Diagnostics, Inc. Reports Second Quarter 2025 Financial Results

Jul 31, 2025, 9:30 AM EDT - 11 months ago

Co-Diagnostics, Inc. Announces Second Quarter 2025 Earnings Release Date and Webcast

Jul 15, 2025, 9:30 AM EDT - 1 year ago

Co-Diagnostics, Inc. to Host Booth at WHX Kuala Lumpur on July 16-18, 2025

May 14, 2025, 9:30 AM EDT - 1 year ago

Co-Diagnostics, Inc. to Participate in D. Boral Inaugural Global Conference

csabuus Jun. 25 at 6:43 AM

$CODX GO to 10

0 · Reply

Minutiae Jun. 25 at 4:16 AM

$CODX Jun 24 Full day chart. https://www.nasdaq.com/market-activity/stocks/codx

0 · Reply

Minutiae Jun. 25 at 4:15 AM

0 · Reply

SmallPhish Jun. 25 at 3:45 AM

$CODX Dwight should be ready to raise money through stock sales tomorrow now that Ebola traders are triggered.

1 · Reply

CoffeeRocks Jun. 25 at 2:39 AM

$CODX https://share.google/2krq8E4kSSOwJ81o6

0 · Reply

CoffeeRocks Jun. 25 at 2:33 AM

$BTAI $RLAY $ABSI $CODX Bio stocks running 🏃‍♂️

0 · Reply

CoffeeRocks Jun. 25 at 1:44 AM

$CODX $AEMD $BTAI $SLS https://share.google/iINko0bnsVQxj6xLn

0 · Reply

Minutiae Jun. 25 at 12:02 AM

0 · Reply

Chessdoc Jun. 24 at 11:55 PM

$CODX Let’s get a move on! https://www.unicefusa.org/stories/3-million-children-risk-ebola-cases-top-1000-drc

0 · Reply

Chessdoc Jun. 24 at 8:41 PM

$CODX Exquisitely, beautiful chart!

0 · Reply

Chessdoc Jun. 24 at 8:35 PM

$CODX Don’t forget an agent that has already shown 100% survival response (albeit in animal studies): Ampligen $AIM

0 · Reply

Chessdoc Jun. 24 at 8:33 PM

$CODX Nice! https://www.reuters.com/world/trump-to-seek-more-than-14-billion-ebola-funding-congress-2026-06-24/

0 · Reply

Dovkav Jun. 24 at 8:27 PM

$CODX trump opened his mouth about ebola. 👍 👌 👍

0 · Reply

csabuus Jun. 24 at 8:19 PM

$CODX Why up?

0 · Reply

Dovkav Jun. 24 at 8:16 PM

$CODX Its always has been brilliant after hours runner 🚀

0 · Reply

splendor Jun. 24 at 8:16 PM

$SNGX Connect the dots: Trump requests $1.4B+ for Ebola emergency . Gavi & UNICEF announce $40M funding for Bundibugyo strain vaccine today. SNGX is one of the only plays with a heat-stable solution for this exact outbreak. Grants are coming. Load up before the PR hits! https://www.internazionale.it/ultime-notizie-reuters/2026/06/24/exclusive-trump-to-seek-more-than-1-4-billion-in-ebola-funding-from-congress $CODX $MRNA

1 · Reply